PD-L1/PD-1 axis is an important immune checkpoint, which can promote the tumor cell escape from immune monitoring, and the PD-L1/PD-1 inhibitors as ICIs are widely used in clinical for the treatment of varieties of cancers (22). Here, CD274 is linked to cancer.